Medtronic investors see no silver lining

Shares of Medtronic plunged this week immediately after the company reported third-quarter ICD sales came in at $711 million, off by 2 percent. Less impressive to investors, evidently, was that the company's earnings beat analyst expectations and surpassed results from the year-ago quarter.